This sources sought notice is seeking capability statements from vendors for a cost-per-reportable agreement to provide coagulation testing reagents, instrumentation, consumables, and services to the San Antonio Military Medical Center. The required testing includes PT, PTT, fibrinogen, D-dimer, and anti-Xa to be performed on primary and backup analyzers in the core laboratory and emergency department from fiscal years 2023 through 2027. Vendors must demonstrate the ability to provide FDA-approved reagents for the named tests and analyzers that fit specified dimensions. The capability statement should address objectives such as analyzer features like random access, scalability, integration with the MHS Genesis system, quality control programs, and maintenance services. The contractor must deliver an analyzer before October 1, 2022 that meets performance requirements such as throughput, test times, and linear measurement ranges. Responses will be used for planning purposes only and are not binding offers.